z-logo
Premium
Determinants of response to intravenous hydralazine in hypertension
Author(s) -
Shepherd Alexander,
Lin MinShung,
McNay John,
Ludden Thomas,
Musgrave Gary
Publication year - 1981
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1038/clpt.1981.237
Subject(s) - hydralazine , medicine , dosing , blood pressure , pharmacology , intravenous infusions , clinical pharmacology , pharmacokinetics , systemic circulation , drug response , drug , anesthesia
There is marked interindividual variation in hypotensive response to intravenous hydralazine (H). We examined the determinants of response in patients with hypertension. After a single intravenous dose of 0.3 mglkg H, response was correlated independently (r = 0.8364) with both predrug blood pressure and acetylator index (AI). Intravenous dose ranging studies showed that response also depended on the amount of H in the systemic circulation. Although plasma H levels depend on AI after oral doses, this is not so after intravenous administration. AI must therefore affect response to H by an alternative, presumably nonmetabolic mechanism which, after oral dosing, would add to its effect on H levels. Response to intravenous nitroprusside was not related to AI, perhaps indicating specificity of this effect for H. These data reinforce the potential usefulness of determining Al before giving H to a patient. Clinical Pharmacology and Therapeutics (1981) 30 , 773–781; doi: 10.1038/clpt.1981.237

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom